SCHEMBL6932928

SCHEMBL6932928

CC(C)N(CCO)c1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 9/20 0.66
CDK1 P06493 9/20 0.66
CCNE2 O96020 7/20 0.66
CCNE1 P24864 7/20 0.66
CDK2 P24941 7/20 0.66
CDK5R1 Q15078 7/20 0.66
KDM4E B2RXH2 5/20 0.66
CCNB1 P14635 4/20 0.66
CCNB2 O95067 3/20 0.66
CCNB3 Q8WWL7 3/20 0.66
ALDH1A1 P00352 2/20 0.66
INSR P06213 2/20 0.66
PRKACA P17612 2/20 0.66
CCNA2 P20248 2/20 0.66
PRKACG P22612 2/20 0.66
PRKACB P22694 2/20 0.66
MAPK3 P27361 2/20 0.66
CCNA1 P78396 2/20 0.66
NTRK1 P04629 1/20 0.66
NTRK2 Q16620 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6934104 0.86 CDK5 (0.63) CDK5CDK1CCNE2CCNE1CDK2
SCHEMBL3311123 0.83 CDK5 (0.79) CDK5CDK1CCNE2CCNE1CDK2
SCHEMBL1325062 0.82 CDK5 (0.70) CDK5CDK1CCNE2CCNE1CDK2
SCHEMBL569370 0.81 CDK5 (0.81) CDK5CDK1CCNE2CCNE1CDK2
SCHEMBL14845886 0.81 CDK5 (0.84) CDK5CDK1CCNE2CCNE1CDK2
Purvalanol B SCHEMBL23509845 0.79 CDK5 (1.00) CDK5CDK1CCNE2CCNE1CDK2
Purvalanol B SCHEMBL6932922 0.79 CDK5 (1.00) CDK5CDK1CCNE2CCNE1CDK2
Purvalanol B SCHEMBL27951 0.79 CDK5 (1.00) CDK5CDK1CCNE2CCNE1CDK2
Purvalanol B SCHEMBL29546074 0.79 CDK5 (1.00) CDK5CDK1CCNE2CCNE1CDK2
SCHEMBL6205009 0.79 CDK5 (0.44) CDK5CDK1CCNE2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6524800-B2 Genetic engineering; adjusting gene expression AFFYMETRIX, INC. 2003-02-25 US disclosed
US-20010055771-A1 Exploiting genomics in the search for new drugs AFFYMETRIX, INC. 2001-12-27 US disclosed